← ANALYST RATINGS · TIPRANKS
Dianthus Therapeutics (DNTH): analyst forecast and price target
Price targets and ratings of
Analyst consensus
Strong Buy11 Buy0 Hold0 Sell
Ratings of 11 analysts in the last 3 months · top analysts only12-month forecast
$142+97.3% upside
Based on 11 price targets given in the last 3 months, the average target is $142, the highest $200, the lowest $122. The average is +97.3% from the last price of $72.09.
Highest target $200
Average target $142
Lowest target $122
Analyst ratings 19
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Swayampakula Ramakanth★★★★★★★★★★#445 · hits 47% · avg +21.2% | H.C. Wainwright | $158 | Buy | +119.2% | Reiterated | 15.10.26on TipRanks 12:45 | −0.6%next day −2.2% | ↗ |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $83.00 → $73.00−12.0% | Hold | +1.3% | Reiterated | 15.10.26on TipRanks 06:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $88.00 → $77.00−12.5% | Hold | +6.8% | Reiterated | 14.10.26on TipRanks 10:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $91.00 → $74.00−18.7% | Hold | +2.6% | Downgrade | 14.10.26on TipRanks 10:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $86.00 → $76.00−11.6% | Hold | +5.4% | Reiterated | 14.10.26on TipRanks 10:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $87.00 → $74.00−14.9% | Hold | +2.6% | Reiterated | 14.10.26on TipRanks 10:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $92.00 → $74.00−19.6% | Hold | +2.6% | Downgrade | 14.10.26on TipRanks 10:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $88.00 → $83.00−5.7% | Hold | +15.1% | Reiterated | 14.10.26on TipRanks 10:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $91.00 → $88.00−3.3% | Hold | +22.1% | Reiterated | 11.10.26on TipRanks 00:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $94.00 → $91.00−3.2% | Buy | +26.2% | Reiterated | 11.10.26on TipRanks 00:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $88.00 → $86.00−2.3% | Hold | +19.3% | Reiterated | 11.10.26on TipRanks 00:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $90.00 → $87.00−3.3% | Hold | +20.7% | Reiterated | 11.10.26on TipRanks 00:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $95.00 → $92.00−3.2% | Buy | +27.6% | Reiterated | 11.10.26on TipRanks 00:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $90.00 → $88.00−2.2% | Hold | +22.1% | Reiterated | 11.10.26on TipRanks 00:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $94.00 → $91.00−3.2% | Hold | +26.2% | Reiterated | 09.10.26on TipRanks 00:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $98.00 → $94.00−4.1% | Buy | +30.4% | Reiterated | 09.10.26on TipRanks 00:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $92.00 → $88.00−4.3% | Hold | +22.1% | Reiterated | 09.10.26on TipRanks 00:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $93.00 → $90.00−3.2% | Hold | +24.8% | Reiterated | 09.10.26on TipRanks 00:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $98.00 → $95.00−3.1% | Buy | +31.8% | Reiterated | 09.10.26on TipRanks 00:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $94.00 → $90.00−4.3% | Hold | +24.8% | Reiterated | 09.10.26on TipRanks 00:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $95.00 → $94.00−1.1% | Hold | +30.4% | Reiterated | 05.10.26on TipRanks 00:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $93.00 → $95.00+2.2% | Hold | +31.8% | Reiterated | 03.10.26on TipRanks 00:06 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $97.00 → $98.00+1.0% | Buy | +35.9% | Reiterated | 03.10.26on TipRanks 00:06 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $91.00 → $92.00+1.1% | Hold | +27.6% | Reiterated | 03.10.26on TipRanks 00:06 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $92.00 → $93.00+1.1% | Hold | +29.0% | Reiterated | 03.10.26on TipRanks 00:06 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $97.00 → $98.00+1.0% | Buy | +35.9% | Reiterated | 03.10.26on TipRanks 00:06 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $93.00 → $94.00+1.1% | Hold | +30.4% | Reiterated | 03.10.26on TipRanks 00:06 | — | |
| Swayampakula Ramakanth★★★★★★★★★★#445 · hits 47% · avg +21.2% | H.C. Wainwright | $158 | Buy | +119.2% | Reiterated | 01.10.26on TipRanks 10:20 | +0.1%next day −0.9% · 5 days −8.0% | ↗ |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $95.00 → $93.00−2.1% | Hold | +29.0% | Reiterated | 01.10.26on TipRanks 00:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $98.00 → $97.00−1.0% | Buy | +34.6% | Reiterated | 01.10.26on TipRanks 00:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $92.00 → $91.00−1.1% | Hold | +26.2% | Reiterated | 01.10.26on TipRanks 00:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $93.00 → $92.00−1.1% | Hold | +27.6% | Reiterated | 01.10.26on TipRanks 00:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $99.00 → $97.00−2.0% | Buy | +34.6% | Reiterated | 01.10.26on TipRanks 00:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $94.00 → $93.00−1.1% | Hold | +29.0% | Reiterated | 01.10.26on TipRanks 00:05 | — | |
| Rami Katkhuda★★★★★★★★★★#297 · hits 55% · avg +31.7% | LifeSci Capital | $125 | Buy | +73.4% | Reiterated | 29.09.26on TipRanks 14:06 | −0.6%next day +1.2% · 5 days −4.0% | ↗ |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $95.00 | Hold | +31.8% | Reiterated | 29.09.26on TipRanks 00:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $98.00 | Buy | +35.9% | Reiterated | 29.09.26on TipRanks 00:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $92.00 | Hold | +27.6% | Reiterated | 29.09.26on TipRanks 00:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $93.00 | Hold | +29.0% | Reiterated | 29.09.26on TipRanks 00:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $99.00 | Buy | +37.3% | Reiterated | 29.09.26on TipRanks 00:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $94.00 | Hold | +30.4% | Reiterated | 29.09.26on TipRanks 00:05 | — | |
| Brian Cheng★★★★★★★★★★#1122 · hits 55% · avg +14.0% | J.P. Morgan | — | Buy | — | Reiterated | 24.09.26on TipRanks 11:30 | −2.8%next day −2.9% · 5 days −2.2% | ↗ |
| Myles Minter★★★★★★★★★★#92 · hits 61% · avg +34.9% | William Blair | — | Buy | — | Reiterated | 18.09.26on TipRanks 05:55 | −4.4%next day −1.9% · 5 days −9.8% | ↗ |
| Samantha Semenkow★★★★★★★★★★#6889 · hits 47% · avg +0.7% | Citi | $156 | Buy | +116.4% | Initiated | 04.09.26on TipRanks 06:15 | +0.6%next day +1.5% · 5 days +0.8% | ↗ |
| Alex Thompson CFA★★★★★★★★★★#60 · hits 73% · avg +50.6% | Stifel Nicolaus | $133 | Buy | +84.5% | Reiterated | 13.08.26on TipRanks 11:35 | −3.2%next day +6.0% · 5 days +1.9% | ↗ |
| Gavin Clark-Gartner★★★★★★★★★★#172 · hits 68% · avg +40.8% | Evercore ISI | $134 | Buy | +85.9% | Reiterated | 10.08.26on TipRanks 08:40 | +2.7%next day −2.6% · 5 days +2.8% | ↗ |
| Danielle Brill★★★★★★★★★★#566 · hits 56% · avg +16.1% | Truist Financial | $110 → $128+16.4% | Buy | +77.6% | Reiterated | 06.08.26on TipRanks 07:35 | −2.1%next day −1.5% · 5 days −1.5% | ↗ |
| Swayampakula Ramakanth★★★★★★★★★★#445 · hits 47% · avg +21.2% | H.C. Wainwright | $130 → $158+21.5% | Buy | +119.2% | Reiterated | 06.08.26on TipRanks 06:15 | −2.1%next day −1.5% · 5 days −1.5% | ↗ |
| Yatin Suneja★★★★★★★★★★#120 · hits 57% · avg +33.0% | Guggenheim | $200 | Buy | +177.4% | Reiterated | 05.08.26on TipRanks Aug 6 06:56 | +2.1%next day −2.1% · 5 days −0.4% | ↗ |
| Laura Chico★★★★★★★★★★#527 · hits 54% · avg +14.2% | Wedbush | $105 → $122+16.2% | Buy | +69.2% | Reiterated | 05.08.26on TipRanks 08:10 | +2.1%next day −2.1% · 5 days −0.4% | ↗ |
| Sadia Rahman★★★★★★★★★★#5292 · hits 70% · avg +11.8% | Wells Fargo | $135 | Buy | +87.3% | Reiterated | 05.08.26on TipRanks 07:45 | +2.1%next day −2.1% · 5 days −0.4% | ↗ |
| William Maughan★★★★★★★★★★#1398 · hits 46% · avg +16.2% | Clear Street | $130 | Buy | +80.3% | Reiterated | 05.08.26on TipRanks Aug 4 20:50 | +2.1%next day −2.1% · 5 days −0.4% | ↗ |
| Yaron Werber★★★★★★★★★★#117 · hits 59% · avg +28.0% | TD Cowen | $150 | Buy | +108.1% | Assigned | 05.08.26on TipRanks Aug 4 20:10 | +2.1%next day −2.1% · 5 days −0.4% | ↗ |
| Maury Raycroft★★★★★★★★★★#1326 · hits 44% · avg +12.0% | Jefferies | $132 | Buy | +83.1% | Reiterated | 15.06.26on TipRanks 10:15 | −1.2%next day −3.8% · 5 days +8.6% | ↗ |
| Ryan Deschner★★★★★★★★★★#506 · hits 69% · avg +41.7% | Raymond James | — | Buy | — | Reiterated | 12.06.26on TipRanks 15:05 | +6.8%next day −1.2% · 5 days +5.8% | ↗ |
| Andy Chen★★★★★★★★★★#959 · hits 67% · avg +28.8% | Wolfe Research | $98.00 | Buy | +35.9% | Reiterated | 08.04.26on TipRanks 16:45 | +4.2%next day −2.0% · 5 days −1.8% | ↗ |
| Colleen M. Kusy★★★★★★★★★★#12105 · hits 35% · avg −6.9% | Robert W. Baird | $67.00 → $132+97.0% | Buy | +83.1% | Reiterated | 09.03.26on TipRanks 12:45 | +20.6%next day +9.9% · 5 days −0.2% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering Dianthus Therapeutics
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $143 at a price of $88.05 (+62.2%); now: $143 at $72.09 (+98.1%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 5 | 5 | 5 | 1 | 3 |
| Buy | 20 | 17 | 16 | 18 | 15 | 14 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 05.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $-0.94 (from $-1.13 to $-0.39). Last quarter: $-0.90.
Sales
Next quarter’s sales estimate — $0M (from $0M to $1M). Last quarter: $1M.
Best top-analyst consensus in the sector · Healthcare
About Dianthus Therapeutics
- CEO: Marino Garcia
- Employees: 92
- 7 Times Square, New York, NY, 10036, US
- dianthustx.com
Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal antibody engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein; and DNTH212, a bifunctional fusion protein that targets plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell function. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.
Data from the stock’s TipRanks forecast page, read 48 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗